Considering absence of invasiveness and side effects, tears emerge as a particularly attractive fluid for biomarker discovery and therefore for daily clinical use. However, to date this fluid remains poorly studied in healthy condition. Here, we present an updated in-depth characterisation of the human healthy tear protein composition using proteomics approach. Both eyes of 8 healthy controls (4 men and 4 women, average age: 38 ± 18) were collected using the Schirmer's strip method. After liquid digestion and off-gel electrophoresis fractionation, three independent proteomics analyses were performed on a LTQ-Orbitrap Velos Pro. Globally, 1351 proteins were identified with 2 unique peptides and 1% FDR. Gene ontology analyses showed up that 39% of the tear proteins were enzymes, with high numbers of dehydrogenases, phosphatases, kinases and ligases. Immunoglobulins, serpins and 14-3-3 domains proteins also emerged as the main tear protein families. The glycolysis and the coagulation and complement cascades, which were already shown in tears as involved in ocular and systemic diseases, were highlighted performing pathway analyses. Our study therefore complements the existing data on healthy tears proteome. Nevertheless, extensive studies for deeply and definitively characterise this promising fluid are required in the near future in order to be able to routinely use this fluid in clinics. A better understanding of its protein content will probably open new avenues in the biomarker discovery and clinical practice in the near future.
Introduction
It is now well known that tears play a key role in the correct function and health status of the eye by providing oxygen and nutriments to the ocular surface cells and improving the optical properties of the eye (lubricating eye surface). Furthermore, tear fluid protects the eye's epithelium thanks to antibacterial properties and by flushing contaminants from the ocular surface. Surprisingly, until now tears and their clinical relevance have been relatively poorly studied. This is particularly illustrated by searching the keywords "Eye tears and biomarkers" in Pubmed. Only 268 items were found during the two last decades (between 1998/01 and 2018/01). In the same period, 264′224 publications containing the words "blood" and "biomarkers" were published. However, with non-invasive, easy and rapidly collected samples, tear-based approaches open up new routes for diagnostic methods and for deeper understanding both ocular and systemic diseases. Differences in the tear protein pattern of patients suffering from diabetic retinopathy (Csosz et al., 2012; Kim et al., 2012; Park et al., 2008) , Graves' Orbitopathy (Pieragostino et al., 2015; Ujhelyi et al., 2012) , dry eye disease (Perumal et al., 2016; Zhou et al., 2009; Aluru et al., 2012 Aluru et al., , 2017 Postnikoff et al., 2018; Jung et al., 2017) , multiple sclerosis (Del Boccio et al., 2016; Salvisberg et al., 2014) and even breast cancer (Lebrecht et al., 2009) or renal failure (Terekhina and Petrovich Iu, 1994) have already been highlighted. Consequently, the ability to measure modifications in human tear content offers promising opportunities for screening not only ocular but also systemic diseases and for discovering potentially new biomarkers for these clinical situations.
At this stage, in order to be as performing as possible, the use of tears for biomarker discovery and clinics requires well knowing and understanding their global protein content, mainly in healthy subjects. To the best of our knowledge, to date, only three major studies (Aass et al., 2015; de Souza et al., 2006; Zhou et al., 2012) deeply investigated the proteome of human healthy tears. Even if these studies https://doi.org/10.1016/j.exer.2018.10.006 Received 11 May 2018; Received in revised form 1 September 2018; Accepted 11 October 2018 are technically and biologically relevant, this is probably not enough to definitively close the question of the complex composition of this fluid in healthy condition. However, in the last three years, there was an increasing number of published papers about tear proteomics, in both ocular and systemic diseases (Aluru et al., 2017; Jung et al., 2017; Gerber-Hollbach et al., 2018; Kallo et al., 2016; Kishazi et al., 2018; Tang et al., 2018) . It is not easy to understand or explain why tears, unlike other biological fluids, just start to arouse real clinical interest. It is likely that the relatively low volumes available for collection contributed significantly to the low numbers of 'omics' studies reported so far. Indeed, an average between 5 and 15 μl of tears can be collected per eye, which is not sufficient for some 'omics' technics (for example, Nuclear Magnetic Resonance usually required around 100 μl of sample). Due to their localisation close to the eye, for a long time tears were probably not considered as a relevant biofluid to study systemic diseases. Moreover, such as albumin in blood, tears contain some abundant proteins that makes more difficult the detection of other proteins. In previous studies investigating tear proteome, either the pool of samples were rather small (one sample for de Souza et al. (2006) and four samples for Zhou et al. (2012) ) or the protein list was obtained with several extraction methods from the Schirmer strip (Aass et al. (2015) ). In this context, we designed our study with eight samples divided in three pools for our experiments and we used only one extraction method from the Schirmer. Moreover, we fractionated our peptides thanks to the off-gel electrophoresis method, which was not well described for tear investigation yet. To conclude, compared to the previous articles, we made improvements that allowed to enhance tear understanding. In this context, using mass spectrometry-based approaches, our study proposes an updated and extended list of tear proteins which could be used as additional reference list for clinical applications in the field of the biomarker research.
Material and methods

Subjects
Healthy subjects (N = 8; experiment 1: 2 women aged 59 and 61 years; experiment 2: 1 woman, 2 men, aged 21, 24 and 60 years respectively; experiment 3: 1 woman, 2 men aged 26, 24 and 26 years respectively) were included in this study. Inclusion criteria were: subjects aged ≥18 and ≤ 70 years, any gender and ethnicity, mm of Schirmer > 10 mm in 5 min. Exclusion criteria were: any eye allergy, conjunctivitis, any eye pathology, acute infectious disease, make-up or contact lenses, cancer and/or chronic autoimmune disease. In accordance with the Declaration of Helsinki, written informed consents were obtained from these subjects. The cantonal ethics committee for research on human beings has approved the patient's informed consent form and the use of biological material (approbation N°516/12, Dec 2012).
Sample collection
Tears were collected using Schirmer-Plus ® paper strip (Biotech Vision Care PVT LTD, Gujarat, India). To avoid any discomfort to subjects, collection was restricted to a maximum of 5 min. No external stimulation was done to collect the basal fluid. Topical anaesthesia should be avoided because it reduces tear production. For each patient, tear samples were taken from both eyes. Persons collecting tears wore gloves in order to avoid any contamination. Care was taken to avoid damage to the conjunctive surface and local eye irritation. External factors such as harsh lighting, background noise and extreme room temperature, all known to affect the content of samples, were strictly supervised in order to ensure satisfactory reproducibility. Moisture length (mm) of Schirmer strip for the cohort was reported (Table 1) .
The strip was then inserted in a tube on ice and centrifuged at 7840 g for 7 min at 4°C without any additional buffer, as described elsewhere (Kishazi et al., 2018; Posa et al., 2013; Remington et al., 2009) . After centrifugation, tear samples were immediately stored at −80°C until analysis. In order to verify the absence of cellular contamination in our samples, we performed a haematoxylin and eosin (H&E) stain in order to color the potential cells. 5 μl of tears were deposited on a slide. The slide was heated 5 min at 60°C then fixed with 50 μl of 10% formalin (10 min). 3 washes were done with H2O and another stain was done with 20 μl of Hemalun (5 min). The slide was washed 3 times with H2O, stained with 20 μl of Eosin (5 min), washed 3 times with H2O then 3 times with 10% alcohol. The slide was finally washed 3 times with the Neo-Clear solution (Merck, Darmstadt, Deutschland). The same protocol was applied to the positive control, i.e. human astrocytes (around 5′000 cells, suspended in PBS 1X, added on a Schirmer strip and centrifuged under the same conditions as for control tear strip) and negative control, i.e. PBS. The conclusion was that the Schirmer's method did not induce cell contamination in our samples.
Total protein assay
The protein concentration of the pooled tear sample (from both eyes of each subject) was determined by performing a Bradford Assay according to manufacturer's recommendations (Protein assay Dye reagent concentrate, Bio-Rad, Hercules, US-CA). The absorbance was measured at 595 nm with a spectrophotometer (Ultrospec 2100 Pro, Amersham Biosciences) and the protein concentrations of the three pools were determined using a bovine serum albumin (BSA) calibration curve. They were estimated at 12.9 μg/μl, 11.06 μg/μl and 9.4 μg/μl for the experiments 1, 2 and 3 respectively.
Reduction, alkylation and digestion
Three independent proteomics experiments were done. Experiment 1 was performed with a pool of two healthy subjects, experiments 2 and 3 were done using two different pools of three healthy subjects (both eyes of the subjects in all three experiments). 60 μg of proteins were used for all experiments. They were dried under speed-vacuum; then urea (33 μl of 6M; Merck, Darmstadt, Deutschland) diluted in Triethylammonium bicarbonate buffer (0.1M; TEAB, Sigma-Aldrich, Saint Louis, US-MO) and tris-(2-carboxyethyl)phosphine (2 μl of 50 mM; TCEP, Sigma-Aldrich, Saint Louis, US-MO) were added in each tube. After incubation at 37°C during 1 h, iodoacetamid (1 μl of 400 mM; Sigma-Aldrich, Saint Louis, US-MO) was added and tubes were incubated 30 min of in the dark. TEAB (67 μl of 0.1M) was added, then a liquid trypsin digestion (1:20 ratio, 1 μg of enzyme to 20 μg of protein, porcine origin, Promega Corporation, Madison, US-WI) was done overnight at 37°C.
Off-gel electrophoresis (OGE)
Before OGE, samples were dried under speed-vacuum then purified by using Macrospin columns (Harvard Apparatus, Holliston, US-MA) according to manufacturer's recommendations. Tubes were dried under speed-vacuum and A 3100 OFFGEL Fractionator (Agilent technologies, Santa Clara, US-CA) was performed over night to separate the sample. Guidelines available in Agilent datasheet were followed, using a 13 cm IPG strip (Immobiline DryStrip pH 3-10, 13 cm GE Healthcare, Little Chalfont, UK) and 12 OGE wells (Moreda-Pineiro et al., 2014; Dayon et al., 2010) . After fractionation, microspin columns (Harvard Apparatus, Holliston, US-MA) were used according to the manufacturer's recommendations and the 12 fractions of each experiment were dried under speed-vacuum. Peptide concentration of the fractions was theoretically approximated, considering that 1/12 of the pooled sample was found in each fraction after OGE.
Mass spectrometry (MS) analyses
The fractions resulting from OGE were dissolved in 94.9% H2O/5% Acetonitrile (ACN)/0.1% Formic acid (FA). For the three experiments, 1 μg of fraction was injected in GPF4 mode (Scherl et al., 2008) , meaning that each fraction of each experiment was injected four times (GPF1, GPF2, GPF3 and GPF4). They were analysed by tandem MS (Liquid Chromatography-MS/MS) using a Linear Trap Quadrupole (LTQ) Orbitrap Velos Pro (ThermoFisher instruments, San Jose, US-CA) coupled to a nanoflow high pressure liquid chromatography (HPLC, NanoAcquity system from Waters, Milford, US-MA). Peptides were trapped on a home-made 5 μm 200 Å Magic C18 AQ (Michrom) 0.1 × 20 mm pre-column and separated on a commercial 0.075 × 150 mm Nikkyo (Nikkyo Technology, Tokyo, JPN) analytical nanocolumn (C18, 5 μm, 100 Å). More precisely, trapping was done during 15 min with a flow rate of 3 μl/min using a gradient of H2O/FA 99.9%/0.1% (solvent A) and CH3CN/FA 99.9%/0.1% (solvent B), where 95% of solvent A were mixed with 5% of solvent B. Then the analytical separation was run for 85 min with a flow rate of 220 nl/min as follows: 0-1 min 95% A and 5% B, 1-55 min 65% A and 35% B, 55-65 min 20% A and 80% B, 65-67 min 20% A and 80% B, 67-69 min 95% A and 5% B and 69-85 min 95% A and 5% B. min. For MS survey scans, the OT resolution was set to 60000 and the ion population was set to 5 × 105 with an m/z window from 400 to 2000. Five precursor ions were selected for collision-induced dissociation (CID) in the LTQ. The normalised collision energies were set to 35% for CID. The different m/z windows for the gas-phase fractions were set as following: 400-520 for GPF1, 515-690 for GPF2, 685-979 for GPF3 and 974-2000 for GPF4. Exclusion duration was set at 45 s, with a repeat count of 1. Exclusion was done by mass, with a low m/z = 0.1 and a high m/z = 1.1. Peak lists and resulting files, combined from the different experiments, were searched against the uniprot_sprot (2017_05_10) database using Thermo Proteome Discoverer (version 2.2.0388; Thermo Fisher Scientific, San Jose, US-CA). Oxidised methionine was set as variable amino acid modifications and carbamidomethylation of cysteines were set as fixed modification. Trypsin was selected as the enzyme, with one potential missed cleavage. The precursor mass tolerance and the fragment mass tolerance were 10 ppm and 0.6 Da respectively. A false discovery rate (FDR) of 1% was selected at peptide and protein levels and only the Master proteins were kept. The list of identified protein was generated containing proteins matching with two different and unique peptide sequences. The datasets supporting the conclusions of this article are available in the ProteomeXchange Consortium repository via the PRIDE database (submission identifier: PXD008702).
Process and pathway analyses
Database for Annotation, Visualization and Integrated Discovery (DAVID), a web-accessible program, was used to perform the Gene Ontology (GO) Analysis classification of the identified proteins (Huang et al., 2009 ). Options were the following: high classification stringency and p-Value for the GO term > 0.05. Some subcategories were grouped in order to reduce the numbers of GO categories and simplify the pie charts.
Search Tool for the Retrieval of Interacting Genes/Proteins/ STRING) database was used to classify the proteins into protein families (Szklarczyk et al., 2015) . We considered a count in gene set > 5 and a p-Value > 0.05 for relevant protein families.
Kyoto Encyclopedia of Genes and Genomes (KEGG) was also used to study and visualise the pathways in which the proteins were involved (Kanehisa et al., 2017) . We set a threshold count of 10, with a p-Value and adjusted p-Value (Benjamini-Hochberg correction) > 0.05.
A manual merge of the protein lists obtained with the three experiments was done using Venny (http://bioinfogp.cnb.csic.es/tools/ venny/index.html).
Top 10, 20, 50, 100 and 200 of the most abundant proteins for the three experiments were obtained by classifying the proteins according to their Peptide Spectrum Matches (PSM). PSM of a protein corresponds to the number of identified peptide spectra matched for this protein.
The same classification was done to obtain the top-100 and top-200 of the less abundant proteins of the different experiments.
Results
In order to obtain a robust in-depth characterisation, three independent proteomics experiments were performed on three different pools of healthy tears. Individual and general lists of proteins were then generated, analysed and compared to the literature. The study design is summarised in the graphical abstract. In addition, comparisons between the tear protein content with other ocular fluids will be proposed.
Characterisation of the human tear proteome
By combining all the experiments, 1351 proteins with 2 unique peptides were identified. By excluding the keratins, which are suspected to come from contamination during the tear collect, the original list was finally reduced to 1337 proteins with 2 unique peptides (874, 837 and 1143 proteins for experiment 1, 2, and 3 respectively; global and detailed lists in S1 dataset).
Interestingly, 45.5% (608 proteins) were in common between the three different experiments, which is a good overlapping considering the variabilities induced by intervariability. Other variabilities could also have been induced during trypsin digestion (Walmsley et al., 2013) , off-gel fractionation and mass spectrometry injections (Tabb et al., 2010) . For further analyses, only list of proteins without keratins was considered.
Top-10 of the most abundant proteins for each experiment was highly stable with 7 proteins always found whatever the experiment observed (Table 2) . Interestingly, the PSM corresponding to these 7 proteins represented between 27.7% (experiment 3) and 36.7% (experiment 1) of the total PSM detected. As expected, the rank one protein was the lactotransferrin, one of the major proteins of the tears, involved in the anti-inflammatory and antimicrobial processes (Flanagan and Willcox, 2009 ). This point highlighted the importance of tears to maintain a very clean environment for the eyes. The other six common proteins between our three experiments were lipocalin-1, also known for its antimicrobial activity (Fluckinger et al., 2004) , serum albumin, lysozyme C, immunoglobulin heavy constant alpha 1, immunoglobulin kappa constant and polymeric immunoglobulin receptor. Moreover, even if some differences in term of abundance (PSM number) have been observed, the presence of the 5 first proteins (lactotransferrin, lipocalin-1, lysozyme C, serum albumin, immunoglobulin heavy constant alpha 1) were largely conserved in all experiments. The principal tear proteins are directly secreted by lacrimal glands (lactotransferrin, epidermal growth factor (EGF), tear lipocalin, secretory immunoglobulin A (sIgA)) or by lysosomes (lysozyme, which was found in the three experiments in the top 10 more abundant proteins). However, some serum proteins such as albumin, transferrin, IgG and IgM were also found in the tear fluid probably as a result of passive transport from the blood and are suggestive of serum leakage. It is also known that cell infiltrating conjunctiva (T cells, B cells among others) secrete Igs and cytokines in various conditions (Offiah and Calder, 2009 ). Finally, local contribution of the neighbouring cells releasing proteins in tears cannot be excluded.
By expanding the comparison to the top-20, top-50 or top-100, the percentages of proteins in common were still relatively high (64%, 45.1% and 52.42%, respectively). At the opposite, top-100 and top-200 of the less abundant proteins presented only 0.1% and 1.6% of proteins in common between the three experiments. The relatively low numbers of unique peptides of these less abundant proteins may explain why they were found in some experiments but not in all three.
Biological analyses of the tear proteome
Using the functional annotation-clustering tool from DAVID, the 1337 proteins were classified according to their molecular functions, cellular components and biological processes (Fig. 1a, b and c respectively). The cadherin-binding involved in cell-cell adhesion (62%, with for instance some eukaryotic translation elongation factors and several capping actin proteins) and the enzyme activity (16%, containing a lot of alcohol dehydrogenases and aldo-keto reductase) were the two main subcategories emerging from GO molecular functions. For cellular components, half of the proteins were linked to the cell-cell adherens junction (56%), an observation that was confirmed by the biological process classification (cell-cell adhesion 46%).
Around 39% (518 proteins) of the 1337 proteins appeared to be part of the enzyme protein classes (detailed lists are available as S2 dataset). By classifying these enzymes using UniProt, the three major subclasses were hydrolases (41%, 212 proteins), transferases (27%, 138 proteins) and oxidoreductases (15%, 80 proteins) (Fig. 2) . In the hydrolases category, we highlighted for example the phospholipase A2 (26, 15 and 15 PSMs in the three experiments) but also the lactotransferrin and the lysozyme C, which were present in the three top 10 proteins. Several mitogen-activated protein kinases (mitogen-activated protein kinase 1, 3, 13, 14) were found in the transferases category and the oxidoreductases contained a lot of dehydrogenases such as 4 alcohol dehydrogenases (alcohol dehydrogenase, alcohol dehydrogenase 1B, alcohol dehydrogenase 1C, alcohol dehydrogenase class 4, alcohol dehydrogenase class 3) and retinal dehydrogenase 1.
After noticing the large amount of enzymes in our proteins, we were interested by studying the other major protein families. Using STRING, which is a biological database for protein-protein interactions, it appeared that serpins (10 proteins) and 14-3-3 domain (7 proteins) were among the top five protein families. Both families have been extensively studied for various cellular functions. 14-3-3 family has been shown as a potential marker for ocular hypertension induced by glaucoma (Tezel, 2013) and several serpins such as serpinA1 (serpin peptidase inhibitor clade A member 1) or serpinB1 (plasminogen activator inhibitor-1) were proposed as targets for diagnosis but also therapy in cancer (Farshchian et al., 2011; Kwon et al., 2014; Zheng et al., 2013) . Tracing these proteins in tears, in response to a treatment or to predict patient outcome for examples, could be clinically relevant and open new way to manage cancer patients. Until now, no information related to the eye can be found concerning these protein families, but we may suggest that it is related to the weak overall investigation of tears.
Furthermore, KEGG analyses highlighted two notable biological pathways, the glycolysis/gluconeogenesis (31 proteins, pValue = 4.6 E −14 , with phosphoglycerate kinase (EC 2.7.2.3) and the ATP-dependent 6-phosphofructokinase (EC 2.7.1.11)) (Fig. 3) and the coagulation and complement cascades (38 proteins, pValue = 1.7 E −20 , among other the complement factor H, the complement factor 3 and the CD59 glycoprotein) (Fig. 4) . Alterations of these pathways have been already shown to be involved in some eye diseases such as Age-Related Macular Degeneration (AMD) or diabetic retinopathy (Yokosako et al., 2014; Jha et al., 2007) . Yokosako et al. (2014) described the urinary levels of lactate and pyruvate as deregulated in AMD patients. In the present study, we were able to identify the lactate dehydrogenase and the pyruvate kinase, which may play a role in the deregulation observed by Yokosako et al. (2014) . As the AMD is an ocular disease, it could be relevant to investigate if the levels of these two proteins are also deregulated in tears. Karamichos et al. (2015) highlighted the glycolysis/gluconeogenesis as part of the most significantly affected pathways in case of keratoconus (KC), which is a non-inflammatory corneal disease. They noticed the 1,3 diphosphoglycerate and the 3-phosphoglycerate as significantly up-regulated in patients suffering from KC compared to healthy controls. Interestingly, we identified in tears the glyceraldehyde-3-phosphate dehydrogenase and the phosphoglycerate kinase, which may have an influence on the metabolites studied by Karamichos et al. (2015) . de Souza et al. (2006) also reported in their tear study a high number of hydrolases involved in the glycolysis. Since the glycolysis takes place within the cells, the source of these proteins might be damaged cells. These cells could be epithelial cells covering the eyes but we cannot exclude that lacrimal cells released them. The fact that these proteins were deregulated in a disease context emphasises their role and importance. Regarding the complement and coagulation pathways, proteins that are involved in play a major role in the protection of the ocular surface (Cocuzzi et al., 2001; Willcox et al., 1997) but also in several diseases (Jha et al., 2007) . As one of the tear main functions is protection and lubrication of the eye, it is completely relevant to find some proteins related to these processes. Detecting in patient tears involved at different levels in these pathways is clinically relevant and offer new therapeutic strategies. 2 . Classification of the 518 enzymes identified in our study. Data were obtained using the "enzymes classes" available on UniProt. Details of the content of each category could be found in S2 dataset. Fig. 3 . Glycolysis/Gluconeogenesis pathway obtained using KEGG database (Kanehisa et al., 2017) . Number of genes that are involved in is higher than the number of bold boxes on the figures due to the isoforms of the proteins. It means that one bold box can encompass several proteins. 5. 
Consistency with the existing knowledge
To date, only three major publications focused on healthy tear proteome and reported 491, 1543 and 1526 identified proteins respectively (Aass et al., 2015; de Souza et al., 2006; Zhou et al., 2012) . Summary of these studies compared to our data were described in Table 3 . In order to compare them with our study, the same stringent identification criteria that we used were applied: identification of proteins with at least 2 unique peptides, only reviewed proteins and exclusion of keratins. Subsequent new lists of identified proteins were generated for each study, greatly reducing their lists at 478, 1026 and 662 proteins. By merging all the information (the 3 published studies and our study), 1620 proteins were identified in tears (Fig. 5) . Only 197 proteins (11.2%; S3 dataset) were in common across all 4 studies. Among them, a mean of 55% were found in the top-200 of the most abundant proteins of our experiments (53.6%, 53.3% and 55.3% in the experiment 1, 2 and 3 respectively). At the opposite, between 1% and 7.1% of these 197 proteins were found in the 200 less abundant proteins of the experiments (4.6%, 7.1% and 1% in the experiment 1, 2 and 3 respectively). Therefore, the less abundant proteins are probably the Fig. 4 . Coagulation and complement cascades obtained using KEGG database (Kanehisa et al., 2017) . Number of genes that are involved in is higher than the number of bold boxes on the figures due to the isoforms of the proteins. It means that one bold box can encompass several proteins. AT3: serpin family C member 1; A1AT: serpin family A member 1; A2M: alpha-2-macroglobulin; CD59: CD59 molecule; CPB2: carboxypeptidase B2; CR3: fibrinogen gamma chain; CR4: fibrinogen gamma chain; C1INH: serpin family G member; C1qrs: complement C1q B chain, C1q C chain, C1r, C1s; C2: complement factor 2; C3: complement C3; C4: complement C4A; C5: complement C5; C6, 7, 8, 9: complement C6, C7, C8 alpha chain, C8 beta chain, C9; DAF: CD55 molecule; FB: complement factor B; FD: complement factor D; FH: complement factor H; FI: complement factor I; Fibrinogen: fibrinogen gamma chain, beta chain, alpha chain; F2: coagulation factor 2 (thrombin); F5: coagulation factor 5; F12: coagulation factor 12; F13: coagulation factor 13 B chain; HCII: serpin family D member 1; kallikrein: kallikrein B1; kininogen: kininogen 1; PCI: serpin family A member 5; PLG: plasminogen; α2AP: serpin family F member 2. NM: not mentioned; Lys-C: proteinase lys-C; FT: Fourier transform; †: with 1 peptide and non-reviewed proteins; ‡: with 2 peptides; *: with 2 unique peptides, without keratins and reviewed proteins.
main cause of variability between these studies. This result is in correlation with the low number of shared proteins between the three top-100 and top-200 less abundant proteins of our own experiments. It is then important to enhance the identification of these low abundant proteins, as they are more likely to contain potential biomarkers for diseases than abundant proteins. Furthermore, 425 proteins (24.1%) were described for the first time in our study (S4 dataset), including some translation initiation factors (eukaryotic translation initiation factors 2A and subunit 2, factor 3 subunits A, B, C, D, E, F, M, factors 4 gamma 1 and 2, factor 5), ribosomal proteins (60S ribosomal protein L14, L17, L18a, L22, L23, L24, L3, L30, L32, L9, 40S ribosomal protein S2, S21, S4, S5, S7 and ribosomal protein S6 kinase alpha-1, alpha-3) and mitogen-activated protein kinases 1, 13 and 14. An important point is that around 40% of these 425 proteins were identified at least in two out of our three experiments (S4 dataset), reinforcing our results. If we exclude these 425 specific proteins from our three lists of top-100 and three lists of top-200 less abundant proteins, it does not greatly change the low percentages of shared proteins which were previously found (2% instead of 0.1% between the three top-100 and 5.7% instead of 1.6% between the three top-200). We specifically identified some ribosomal proteins, which are part of small guanosine trisphosphatases (GTPases) (Stenmark and Olkkonen, 2001) . Depending on the binding to guanosine trisphosphate (GTP) or guanosine diphosphate (GDP), Rab proteins (Ras-related in brain) are active or inactive, respectively (Hutagalung and Novick, 2011) . They are involved in the membrane traffic and vesicles formation and transport. Several mitogen-activated protein kinases which are in charge of the signal transduction by the phosphorylation of serine and threonine protein residues were also found (Wada and Penninger, 2004) . They could be released after apoptosis of the cells in contact with tears. Why did we find these proteins specifically in our study and how could we explain the low number of proteins in common (192) between the studies? The use of different technical workflows (Table 3 ) may bring some answers to these questions.
Firstly, the method of sample collection has an impact on tear composition (Posa et al., 2013 ). de Souza et al. (2006 used microcapillary glass tubes whereas the other studies sampled tears with Schirmer's strip. Schirmer method is reported to be more comfortable and pleasant for the collected persons, easier to handle and can not wound neither cornea, nor conjunctiva. On the other side, capillary tube was described as requiring more technical expertise from the person who collected tears. The good angle and position of the capillary on the ocular surface are not trivial, which frequently need capillary tube repositioning. Thereby, more risks to seriously damage the conjunctiva and/or the cornea are associated to this technique. Finally, collection with a capillary tube takes more time since it must be stopped when the patient moves or blinks. Even if this technique is suspected to limit cell contamination from conjunctival or epithelial cells compared to Schirmer collection, this cannot be completely excluded. Posa et al. (2013) concluded that both methods were suitable for protein analyses. Yet, they reported that all subjects experienced the Schirmer strip much more pleasant compared to the capillary tube. Our personal data also support the conclusion of Posa et al. (2013) , so regarding the balances between various advantages and few limitations, we chose the Schirmer test. However, the use of capillary tubes in the study of de Souza et al. (2006) could be part of the reasons why only 197 proteins were commonly found in the 4 studies. Indeed, in the literature higher protein contents and concentrations were obtained using Schirmer strip method (Farias et al., 2013; Green-Church et al., 2008; Stuchell et al., 1984) . Another parameter that was different between the studies is the Schirmer extraction method. Whereas we only centrifuged the Schirmer's strip to collect tears, Zhou et al. (2012) used extraction buffer comprising 100 mM of ammonium bicarbonate and protease inhibitor. Aass et al. (2015) worked with different buffers containing NH4HCO3, NaCl, a surfactant, or a combination of the three, the consequences on recovered proteins following these extraction methods were not investigated yet.
Another different technical point could be the off-gel electrophoresis fractionation (based on the isoelectric point of the peptides) while Aass et al. (2015) and Zhou et al. (2012) used strong cation exchange (SCX) chromatography. It has been proven that both methods were suitable to separate a complex sample and enhance the number of identified proteins (Horth et al., 2006; Chenau et al., 2008) . However, only few studies compared these two methods (Mostovenko et al., 2013; Slebos et al., 2008) . The off-gel electrophoresis provides the isoelectric point of the peptides, a useful information, and shows a high resolution, a high sample loading and a flexibility concerning the choice of the pH gradient ( (Zhou et al., 2012) , Aass et al. (Aass et al., 2015) and us. The following criteria were applied to the four protein lists: only reviewed proteins, 2 unique peptides and exclusion of keratins. For each category, percentage represents the ratio between the proteins contain in this category and the total number of proteins. Major information is the proteins in common to the four studies (197; 11.2%) and our specific proteins (425; 24.1%).
2008). This allows to focus on a specific pH range, to better separate the samples in this pH gradient. The SCX method is described to be a faster method (Moreda-Pineiro et al., 2014) , but evidences about enhancing the number of identified proteins are contradictory (Mostovenko et al., 2013; Waller et al., 2008; Manadas et al., 2009) . As expected, the two methods lead to different protein profiles (Waller et al., 2008; Antberg et al., 2012) , enhancing the interest and relevance of merging different studies. We also would like to mention that we did not measure peptide concentration of the fractions after OG. Regarding the difficulty in quantifying peptides (Tammen and Hess, 2013; Sapan and Lundblad, 2015) and the low quantity of material per fraction, we estimated the concentration by considering a homogeneous quantity of peptides in each fraction.
Peptide length and tryptic missed cleavage sites could also explain the differences between the 4 studies that we observed. While we used LTQ-Orbitrap like Aass et al. (2015) , Zhou et al. (2012) performed their analyses with a TripleTOF 5600. On another hand, Aass et al. (2015) supplemented the trypsin with Lys-C enzyme. This combination of two proteases was described to enhance the efficiency of the digestion, and influences the identified proteins (Saveliev et al., 2013) .
Like Zhou et al. (2012) and Aass et al. (2015) , we pooled different collected samples, while de Souza et al. (2006) analysed one single subject. Pooling different samples permitted to reach a sufficient quantity and work with an average sample in term of peptide content (Oberg and Vitek, 2009 ) in the analysed sample. However, pooling loses the sample identity and the inter-variability information. In our case, we were interested in the global tear proteome so we chose to pool samples.
In our pie charts, we did not obtain the same category names as Zhou et al. (2012) , probably because of a different software version. Nevertheless, the main categories seemed similar for each GO classification, which was completely relevant with the fact that almost 50% (776) of proteins were found in common in their study and our. This observation strengthened our results but also emphasised the need to analyse more samples, to consider the potential effects of physiological parameters (age, gender, circadian rhythm and potential drugs) and to standardise the proteomics workflow.
Our method presents the advantage of not using extraction buffer, compared to Zhou et al. (2012) and Aass et al. (2015) . Therefore, the samples will be available for any kind of experiments and analysis methods, without any interferences. Moreover, no study checked whether the extraction buffer keep the samples well. We warmly recommend, including an equal number of men and women of various ages, to properly cover tear proteome. Indeed, some recent studies started to investigate how both age and sex could influence both tear composition and characteristics (Gibson et al., 2017; Micera et al., 2018; Ozdemir and Temizdemir, 2010) . The use of OGE was also an added value, as this method was only described for tears in another article from our team in a disease context (Salvisberg et al., 2014) . This alternative fractionation method probably contributed to the specifically identified proteins of our study. However, the current methodology has limitations. First, Schirmer strip extraction without buffer will not allow studying ocular diseases leading to dry eye. Indeed, Schirmer moisturising could be too short, resulting in 1 or 2-μl sample, not suitable for further analyses. In these cases, using extraction buffers or other collecting methods such as a polyester fiber rod or microcapillary tube would be more efficient (Aluru et al., 2017; Jung et al., 2017) . Moreover, due to its multiple steps, this methodology is not easy to handle in a clinical study with many samples. However, our goal was to describe a methodology which can be used in the first step of research projects, usually done with limited number of samples.
The tear proteome and the other ocular fluids
The tear proteome generated in our study was then compared to the proteome of vitreous and aqueous humors (VH and AH respectively), investigated among others by Murphy et al. (Murthy et al., 2014 (Murthy et al., , 2015 . So far, VH and AH were not very much studied in term of proteomics studies. VH is a transparent and gelatinous substance situated between the lens and the retina (Bishop, 2000) . Its global proteome, meaning in healthy subjects, was described in only two main studies (Murthy et al., 2014; Aretz et al., 2013) . This fluid should contain some information about the physiological condition of the retina. AH is situated at the anterior and posterior chambers of the eye and plays a crucial role in cleaning the lens and the cornea, but also permitting the distribution of nutriments and drugs to several ocular structures (Goel et al., 2010) . Interestingly, 291 (21.8%) and 197 (14.7%) tear proteins were also found in VH and AH respectively (% of proteins we found in tears; with two peptides, only reviewed and without keratins; S5 and S6 datasets). Proteins found in common were represented by clusterin, recently demonstrated in VH as a potential biomarker of the AMD (Nobl et al., 2016) and suspected to be a marker of Alzheimer disease in plasma (Jongbloed et al., 2015) , but also proteins involved in the glycolysis (among others the lactate dehydrogenases A and B chains and the enolase 1) and complement and coagulation pathways (6 proteins of the serpin family and 16 complement factors). Several cathepsins (B, D, L1 and Z) were also commonly found in both tears, VH and AH. Cathepsin D, identified in the three different ocular fluids, was also recently proposed as biomarker candidate in AH for neovascular AMD (Kang et al., 2014) . Finding in tears some proteins also present in VH and AH and related to certain diseases is very promising. Indeed collecting VH and AH requires surgery, which is an invasive process. Using tears to find the same information could be a real advantage for both clinicians and patients. Moreover, it could allow easier and better identification of proteins of interest in certain pathologies.
The comparisons between tears, AH and VH have some limitations. Indeed, two studies of Murphy (Murthy et al., 2014 (Murthy et al., , 2015 were done with AH and VH of patients with cataract, because the need to a surgery does not permit to collect complete healthy persons. We do not know how the cataract status could affect the results obtained in these studies, and so the comparisons that we made. However, we are aware that these remarks are somewhat speculative and that more experiments will be needed to support our hypothesis.
Conclusion
To conclude, the merge of all tear protein lists has enabled the identification of 1620 proteins (with stringent conditions), suggesting that there is probably place for improvement in tear protein identification. Indeed, the fact that the combination of different studies greatly enhances our knowledge about this fluid clearly demonstrates that additional experiments will be required for the establishment of a reliable proteome for the tears. Through this study, we first complemented the knowledge on tear proteome but we also proposed a global overview of their great potential for clinical research and biomarker discovery.
